Chromosome 16 is one of the most gene-dense and structurally unusual chromosomes in the human genome, carrying roughly 880 protein-coding genes across about 79 million base pairs of DNA. Its high concentration of repeated DNA segments makes it prone to rearrangements that can cause a striking range of health conditions, from obesity and underweight to blood cancers, kidney disease, and neurological disorders. The sheer variety of problems linked to this single chromosome reflects its complexity and the evolutionary forces that shaped it.
Why Chromosome 16 Is Unusually Prone to Rearrangement
About 10% of chromosome 16’s sequence consists of segmental duplications, blocks of DNA that appear in nearly identical copies at different locations along the chromosome. That figure is among the highest of any human autosome. These duplicated segments cluster heavily around the short arm (called 16p), particularly near the centromere. When cells divide and chromosomes pair up, those repeated sequences can misalign, causing chunks of DNA to be accidentally deleted, duplicated, or inverted. The technical name for this process is non-allelic homologous recombination, but the practical result is straightforward: chromosome 16 breaks and reshuffles more often than most chromosomes do.1PubMed Central. Refining the Phenotype of Recurrent Rearrangements of Chromosome 16
The finished sequence of chromosome 16, published in 2004, confirmed this instability. Researchers found 880 confirmed protein-coding genes, 341 pseudogenes, and several large-scale structural differences between individuals that actually changed gene content from person to person. The chromosome hosts entire gene families with medical relevance, including the metallothionein genes involved in metal detoxification and the cadherin genes involved in cell adhesion, alongside well-known disease genes for polycystic kidney disease and a form of acute leukemia.2Nature. The sequence and analysis of duplication-rich human chromosome 16
The tip of the short arm is especially gene-rich. A detailed study of just the terminal 2 megabases of 16p found 100 confirmed genes and 20 predicted genes packed into that small stretch. That density means even a small deletion at the chromosome’s tip can knock out multiple genes at once.3PubMed. Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16
The 16p11.2 Region and Its Mirror Effects on Body Weight
One of the most studied hotspots on chromosome 16 is a roughly 600-kilobase stretch at band 16p11.2. When one copy of this region is deleted, the most consistent effect is severe obesity that often begins in childhood. When the same region is duplicated instead, the effect flips: carriers tend to be underweight. This mirror relationship between deletion and duplication is one of the clearest examples in human genetics of gene dosage directly controlling a major physical trait.
A large study examining these copy-number variants found that half of boys under five carrying the duplication were underweight, with a probable diagnosis of failure to thrive. Adult duplication carriers had an 8.3-fold increased risk of being clinically underweight. In deletion carriers, the picture was the reverse: severe obesity frequently accompanied by excessive appetite and intellectual disabilities.4PubMed Central. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus
A more recent analysis using the UK Biobank reinforced just how dramatically these deletions affect metabolic health. Carriers of a nearby 16p11.2 deletion (spanning a slightly different breakpoint interval) had, on average, nearly 4 kg/m² higher BMI and about 7 kg more total body fat than the general population. Over 40% reported being plumper than average at age 10. The metabolic consequences were stark: carriers faced a roughly sevenfold increased risk of type 2 diabetes, with considerably earlier onset and a higher likelihood of needing insulin treatment.5Cell Reports Medicine. Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease
The clinical picture for 16p11.2 duplications extends well beyond low weight. A case report of a family carrying the duplication documented developmental delay, gastrointestinal dysfunction including chronic abdominal pain and esophageal motility disorder, a forward-leaning gait, mild scoliosis, and limb muscle atrophy with inflammatory muscle involvement in the affected child.6PubMed. Clinical and genetic analysis of a family with 16p11.2 microduplication syndrome and variable multisystem manifestations So while the weight effects grab headlines, both the deletion and duplication can affect the brain, the gut, and the musculoskeletal system in ways that vary considerably from person to person.
Earlier work on 16p11.2 deletions in children highlighted a co-occurrence of severe obesity and developmental delay, with some cases also overlapping a region previously linked to autism.7PubMed Central. Chromosome 16p11.2 deletions: another piece in the genetic puzzle of childhood obesity This overlap partly explains why 16p11.2 deletions are among the most commonly tested copy-number variants in children evaluated for autism spectrum disorder.
How Common Are These Microdeletions and Microduplications
A study of 17,000 prenatal cases that underwent chromosomal microarray analysis found that 81 fetuses, about 0.48%, carried a microdeletion or microduplication on the short arm of chromosome 16. The most frequently affected region was 16p11.2 (36 cases), followed by 16p13.11 (28 cases). Among the 36 fetuses with 16p11.2 changes, 33 had abnormal ultrasound findings, most commonly skeletal abnormalities.8PubMed Central. Molecular Genetic and Clinical Characteristics of Fetuses With Chromosome 16 Short‐Arm Microdeletions/Microduplications These numbers suggest that while any individual rearrangement is rare, collectively they add up to a meaningful fraction of prenatal chromosomal findings.
Prenatal screening methods have improved at detecting these small changes. Chromosomal microarray analysis catches copy-number variants smaller than 5 megabases more reliably than non-invasive prenatal screening through a blood draw; in one high-risk pregnancy study, microarray detected such variants in about 8% of cases versus 3% for cell-free DNA screening.9PubMed. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy For families specifically concerned about chromosome 16 rearrangements, this distinction matters when choosing between screening options.
Trisomy 16 in Pregnancy
Full trisomy 16, where every cell carries three copies of the chromosome instead of two, is the single most common trisomy found in spontaneous miscarriages. It occurs in an estimated 1 to 1.5% of all pregnancies and is almost always lethal early in development.10PubMed Central. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes? The reason it dominates miscarriage statistics likely relates to chromosome 16’s gene density: having 50% extra copies of hundreds of genes overwhelms normal development.
Mosaic trisomy 16, where only some cells carry the extra chromosome while others are normal, is a different story. Pregnancies with mosaic trisomy 16 can survive. An analysis of 162 such pregnancies found that about two-thirds resulted in live birth, though the babies tended to arrive early (average gestational age around 35.7 weeks) and underweight. Among those live births, 45% had at least one malformation, most commonly heart defects like ventricular or atrial septal defects, and hypospadias.11Journal of Medical Genetics. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism So a prenatal finding of mosaic trisomy 16 is serious and warrants close monitoring, but it does not necessarily mean the pregnancy cannot continue.
Deletions at the Tip of 16p and Alpha-Thalassemia
The very tip of chromosome 16’s short arm, band 16p13.3, houses the alpha-globin gene cluster that produces a key component of hemoglobin. Deletions of 1 to 2 megabases from this region cause a condition called ATR-16 (alpha-thalassemia/mental retardation syndrome type 16), which combines a blood disorder with intellectual disability.12PubMed Central. De novo truncation of chromosome 16p and healing with (TTAGGG)n in the alpha-thalassemia/mental retardation syndrome (ATR-16) The alpha-thalassemia component arises from losing one or both alpha-globin genes on the affected chromosome, reducing the body’s ability to make normal hemoglobin. The intellectual disability and mild dysmorphic facial features come from losing neighboring genes in the same deletion.13PubMed. Phenotype-genotype characterization of alpha-thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3
This same 16p13.3 neighborhood also holds the PKD1 gene, responsible for the most common form of autosomal dominant polycystic kidney disease.14PubMed Central. Cosmid walking and chromosome jumping in the region of PKD1 reveal a locus duplication and three CpG islands Polycystic kidney disease affects roughly 1 in 400 to 1 in 1,000 people and is one of the most common life-threatening genetic diseases in the world. Mutations in PKD1 cause fluid-filled cysts to grow throughout the kidneys over decades, gradually impairing kidney function and sometimes requiring dialysis or transplantation.
Inversion of Chromosome 16 and Leukemia
Not all disease-causing changes on chromosome 16 involve pieces being lost or gained. One of the most common chromosomal rearrangements in acute myeloid leukemia is an inversion within chromosome 16 itself, abbreviated inv(16). In this event, a segment of the long arm flips and reattaches in reverse orientation, fusing two genes that are normally far apart: CBFB, which encodes part of a transcription factor, and MYH11, which encodes a smooth muscle protein. The resulting fusion gene, CBFB::MYH11, produces an abnormal protein that disrupts normal blood cell development and drives leukemia.15Oncogene. The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow
The leukemia subtype associated with inv(16) is called acute myelomonocytic leukemia with eosinophilia (sometimes classified as AML-M4Eo). Molecular studies showed that the fusion gene generates an in-frame protein regardless of which of the three known breakpoint types is involved, meaning the abnormal protein is always produced when the inversion occurs.16Blood. Molecular Pathogenesis of the Chromosome 16 Inversion in the M4Eo Subtype of Acute Myeloid Leukemia Paradoxically, this particular subtype of AML carries a relatively favorable prognosis compared to other forms. Patients with inv(16) tend to respond better to chemotherapy, making the chromosomal rearrangement an important factor in treatment decisions.
Neurological Conditions Linked to Chromosome 16
Several single-gene disorders on chromosome 16 affect the nervous system. One of the more dramatic examples involves the PRRT2 gene on 16p11.2, which encodes a protein involved in neurotransmitter release. Mutations in PRRT2 cause a spectrum of paroxysmal neurological conditions, meaning disorders that come in sudden episodes. These include paroxysmal kinesigenic dyskinesia, where brief involuntary movements are triggered by sudden motion, and benign familial infantile seizures. The two conditions can occur together in the same family or even the same individual, effectively representing different expressions of the same genetic defect.17PubMed Central. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine18PubMed. Two faces of the same coin: benign familial infantile seizures and paroxysmal kinesigenic dyskinesia caused by PRRT2 mutations
A much rarer and more devastating condition, Batten disease (juvenile neuronal ceroid lipofuscinosis), results from mutations in the CLN3 gene on chromosome 16. Batten disease causes progressive neurodegeneration in children, typically beginning with vision loss around age 5 to 10 and progressing to seizures, cognitive decline, and loss of motor function. It remains one of the most common neurodegenerative disorders of childhood, though “common” is relative here since it is still extremely rare in absolute terms.19PubMed Central. Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights
The MC1R Gene, Red Hair, and Melanoma Risk
Chromosome 16 also carries a gene with effects you can see in the mirror. The MC1R gene at 16q24.3 encodes the melanocortin-1 receptor, a protein on the surface of pigment-producing cells that influences whether those cells make dark pigment (eumelanin) or reddish-yellow pigment (pheomelanin). Certain loss-of-function variants in MC1R are the primary genetic driver of red hair and fair skin.
A large analysis using the UK Biobank identified both strong-effect and weak-effect MC1R variants contributing to red hair. Three variants in particular (rs1805007, rs1805008, and rs1805009) had strong associations, while three additional variants had real but much weaker effects, with their statistical coefficients differing by two orders of magnitude from the strong variants.20PubMed Central. A study in scarlet: MC1R as the main predictor of red hair and exemplar of the flip-flop effect In forensic genetics, homozygous or compound heterozygous combinations of MC1R variants serve as useful predictors of both red hair color and fair skin.21PubMed. Determination of phenotype associated SNPs in the MC1R gene
The medical significance goes beyond cosmetics. A meta-analysis of 11 studies found that seven MC1R variants were significantly associated with melanoma development, with odds ratios ranging from about 1.4 to 2.5 depending on the variant. Some variants correlated strongly with red hair alone, while others correlated with both red hair and fair skin. The implication is that MC1R variants do not just change hair color: they shift the skin’s pigment balance in ways that reduce natural UV protection and raise melanoma risk.22PubMed. MC1R variants, melanoma and red hair color phenotype: a meta-analysis
Liddle Syndrome and Blood Pressure
A rarer condition tied to chromosome 16 is Liddle syndrome, an inherited form of severe high blood pressure that typically appears early in life. It results from mutations in genes encoding the subunits of the epithelial sodium channel (ENaC) in the kidney. The SCNN1B and SCNN1G genes on chromosome 16 encode the beta and gamma subunits of this channel. Mutations that affect these subunits cause the channel to stay open too long, driving excessive sodium reabsorption and raising blood pressure. As of one review, 31 different causative mutations had been reported across 72 families worldwide.23PubMed Central. Liddle Syndrome: Review of the Literature and Description of a New Case Liddle syndrome is worth knowing about because it mimics primary hypertension but does not respond to standard blood pressure medications. It requires specific drugs that block the ENaC channel, like amiloride. Misdiagnosis can mean years of ineffective treatment.
Crohn’s Disease Susceptibility
Chromosome 16 also harbors genetic variants that influence susceptibility to Crohn’s disease, a chronic inflammatory condition of the digestive tract. The CARD15/NOD2 gene on 16q12 was one of the first genes convincingly linked to Crohn’s risk. Certain variants in this gene are more common in people with Crohn’s disease than in healthy controls. In one study, the combined frequency of three rare CARD15 variants was about 8.7% in Crohn’s patients compared to 3.5% in controls, and one particular variant (1007fs) was significantly associated with the disease. The same variants were also linked to familial cases and to more complicated disease courses.24PubMed Central. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease CARD15/NOD2 encodes a protein involved in the immune system’s recognition of bacterial components, so variants that impair its function can lead to an inappropriate inflammatory response in the gut. This discovery was a landmark in understanding that Crohn’s disease has a strong genetic component involving innate immunity.
Evolutionary Restlessness on Chromosome 16
The segmental duplications on chromosome 16 are not just a source of human disease. They have been a driving force in primate evolution. A particular duplicated segment called LCR16a has independently expanded in at least five primate lineages over the past 35 million years. Each lineage shows its own set of large duplication blocks flanking LCR16a, arising at different chromosomal locations and at different times.25PubMed Central. An evolutionary driver of interspersed segmental duplications in primates Separate work confirmed that this segment has been active independently in each great ape and human lineage, essentially jumping around the genome repeatedly during evolution.26PubMed Central. Recurrent duplication-driven transposition of DNA during hominoid evolution
This kind of evolutionary hyperactivity has consequences. When duplicated segments spread to new locations, they can create new genes, modify existing ones, or set the stage for the misalignment events that cause disease in modern humans. The same mechanism that allowed rapid gene innovation in our primate ancestors is the one that now predisposes chromosome 16 to deletions, duplications, and inversions. It is a trade-off written into the DNA itself: genomic flexibility in evolutionary time, genomic fragility in an individual lifetime.